Anebulo Pharmaceuticals (ANEB) Interest Coverage Ratio (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Interest Coverage Ratio of 150.23 for Q4 2025, down 480.46% year-over-year from 39.49 in Q4 2024, and down 9707.31% quarter-over-quarter from 1.53 in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Interest Coverage Ratio for 6 consecutive years, with 150.23 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 480.46% year-over-year to 150.23; the TTM figure through Dec 2025 stood at 22.87 (up 39.66% YoY), while the FY2025 annual figure was 23.06, up 44.5% from the prior year.
- Interest Coverage Ratio slipped to 150.23 in Q4 2025 per ANEB's latest filing, from 1.53 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1932.12 in Q2 2021 and bottomed at 150.23 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 78.49 across 5 years, with a median of 5.8 in 2023.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio jumped 99.44% — and 2022, when it plunged 6113.38%.
- Anebulo Pharmaceuticals' Interest Coverage Ratio stood at 0.45 in 2021, then slumped by 6113.38% to 27.76 in 2022, then gained by 27.61% to 20.1 in 2023, then dropped by 28.79% to 25.88 in 2024, then slumped by 480.46% to 150.23 in 2025.
- Business Quant data shows ANEB's Interest Coverage Ratio at 150.23 in Q4 2025, 1.53 in Q3 2025, and 65.8 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | -150.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -150.23 |
| Sep 30, 2025 | -1.53 |
| Jun 30, 2025 | -65.80 |
| Mar 31, 2025 | -7.72 |
| Dec 31, 2024 | -25.88 |
| Sep 30, 2024 | -24.12 |
| Jun 30, 2024 | -12.36 |
| Mar 31, 2024 | -4.72 |
| Dec 31, 2023 | -20.10 |
| Sep 30, 2023 | -4.50 |
| Jun 30, 2023 | -0.53 |
| Mar 31, 2023 | -6.89 |
| Dec 31, 2022 | -27.76 |
| Sep 30, 2022 | -7.30 |
| Jun 30, 2022 | -1.04 |
| Mar 31, 2022 | -0.50 |
| Dec 31, 2021 | -0.45 |
| Sep 30, 2021 | -0.59 |
| Jun 30, 2021 | 1,932.12 |
| Mar 31, 2021 | -0.27 |